Matthew W Foehr, Ligand Pharmaceuticals Incorporated's President and COO, recently acquired 1,004 shares of the company. The buys took place at $21.92 per share, on June 11, 2019. Foehr now owns 141,451 shares of the company. Foehr operates out of San Diego, CA. Some additional info was provided as follows:
Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/15/13.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Ligand Pharmaceuticals Incorporated makes a similar move, sign up!